Products

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, has entered into a new, two year, sales agency agreement with privately-held Advanced Oncology Systems.

Integra LifeSciences Holdings Corporation (NasdaqGS:IART ) announced today the appointment of Christopher A. Thatcher as President of Integra NeuroSciences, effective immediately.

Medtronic Inc. has recently been targeted in various lawsuits related to its Infuse Bone Graft, a medical device designed to stimulate bone growth.

Nitinol Devices & Components, Inc. announced today that they recently acquired a novel medical device anchoring technology from Phase One Medical, LLC.

Spine surgeons at Washington University School of Medicine in St. Louis and other U.S. centers are reporting that artificial disc replacement works as well and often better than spinal fusion surgery.

Aspen Surgical Products Holding, Inc. announced today that it completed the acquisition of the Woundcare and Ophthalmic business of Unomedical Limited based in Redditch, U.K.

As the number of hip and knee replacements skyrocket into the coming years, patients and orthopaedic surgeons need to evaluate and assess a potentially fatal complication — blood clots. According to findings released today at the 2009 Annual Meeting of the American Academy of Orthopaedic Surgeons, deep vein thrombosis a type of prophylaxis a patient receives pre and post-joint replacement, causes controversy.

Giving patients with acute vertebral fractures balloon kyphoplasty treatment improves quality of life and reduces disability and back pain compared with conventional non-surgical management, and is a safe and effective technique, finds The Lancet.

Abbott today announced that it has completed its acquisition of Advanced Medical Optics. AMO is now a wholly owned subsidiary of Abbott and has been renamed Abbott Medical Optics Inc.

Zimmer Holdings, Inc., a leader in the orthopaedic industry, today announced that data from an independent 10-year Trabecular Metal™ Technology comparative clinical study demonstrates the osteoconductive properties of Zimmer’s Trabecular Metal Technology.

A newly published report in the Heart Rhythm Society (Washington) journal HeartRhythm shows that there could be a higher rate of failure for the Sprint Fidelis Leads, than previous studies have revealed.

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that is has been issued U.S. Patent 7,422,605,B2 for its rotating bearing knee prosthesis, Optetrak® RBK™.

Kensey Nash Corporation announced that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to study the use of the Company’s unique biomaterials technology for treating articular cartilage defects of the knee.

Bone Biologics, Inc. announced that it has successfully completed the initial primate trials validating the efficacy of the proprietary bone growth regeneration UCB-1 (NELL-1) protein in spinal fusion surgery.

Smith & Nephew’s Orthopeadics business and BrainLAB today announce an agreement by which BrainLAB will become the exclusive vendor for developing and supporting computer-assisted surgical technologies for Smith & Nephew’s high performance hip and knee implants.

Hydromer, Inc. announces the sale of the Endoscopic Bipolar Coagulation probe and Biliary Stent business by its wholly owned subsidiary, Biosearch Medical Products Inc., to Merit Medical Systems Inc. for $1.6 million in cash.